Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
51.1M
-
Number of holders
-
400
-
Total shares
-
46.2M
-
Shares change
-
+521K
-
Total reported value, excl. options
-
$6.7B
-
Value change
-
+$95.9M
-
Put/Call ratio
-
2.75
-
Number of buys
-
178
-
Number of sells
-
-206
-
Price
-
$145.25
Significant Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock (CRL) as of Q1 2019
416 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock as of Q1 2019.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock (CRL) has 400 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.2M shares
of 51.1M outstanding shares and own 90.43% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.22M shares), BlackRock Inc. (4.59M shares), AQR CAPITAL MANAGEMENT LLC (2.08M shares), RENAISSANCE TECHNOLOGIES LLC (1.89M shares), FMR LLC (1.67M shares), STATE STREET CORP (1.17M shares), FIRST TRUST ADVISORS LP (1.1M shares), WELLS FARGO & COMPANY/MN (1.05M shares), TimesSquare Capital Management, LLC (864K shares), and BROWN ADVISORY INC (847K shares).
This table shows the top 400 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.